Indivi
Emmanuel Bartholomé is an experienced professional in the field of neurology and clinical development, currently serving as the Head of Clinical Development at Indivi. Previously, Emmanuel held key positions at Biogen, including Digital Biomarker Clinical Strategy Lead for Biogen Digital Health and Associate Medical Director, Global Medical Science and Clinical Value Lead. Emmanuel has extensive experience as a neurologist specializing in multiple sclerosis at CHU Tivoli, where responsibilities included serving as Vice President of the Medical Council and heading the Neurology Department. Additional roles include Administrator for the Belgian Study Group for Multiple Sclerosis and Chief Medical Officer and Medical Director at Medical Device Works SA. Emmanuel obtained a Doctor of Medicine (M.D.) degree in Medicine with a focus on Neurology and Rehabilitation from Université libre de Bruxelles between 1986 and 1999.
This person is not in any teams
Indivi
1 followers
Indivi is a leading Medtech for the development of digital measurements > biomarkers in neuroscience, headquartered in Basel, Switzerland. Indivi is committed to developing and validating transformative digital endpoints to accelerate and de-risk drug development in neurodegenerative diseases, with a focus on multiple sclerosis, Parkinson’s and Alzheimer’s diseases. Through its exclusive partnership with Basel University Faculty of Medicine and the Research Center for Clinical Neuroimmunology and Neuroscience in Basel (RC2NB), Indivi is dedicated to unlocking the potential of digital endpoints and precision medicine in drug development by creating a fertile symbiotic intersection of knowledge in Data Science, Clinical Science and Advanced Analytics (including machine learning and so-called artificial intelligence).